Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1990
An immunoassay to detect human müllerian inhibiting substance in males and females during normal development
P L Hudson, I Dougas, P K Donahoe, et al.
Journal of Andrology
|
September 8, 2001
Müllerian inhibiting substance inhibits testosterone synthesis in adult rats
V Sriraman, E Niu, J R Matias, et al.
Gynecologic Oncology
|
February 1, 1984
KLE: a cell line with defective estrogen receptor derived from undifferentiated endometrial cancer
G S Richardson, G R Dickersin, L Atkins, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1994
Developmental changes in mullerian inhibiting substance in the cynomolgus monkey, Macaca fascicularis
M M Lee, M L Gustafson, E Ukiyama, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2005
Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model
V Gupta, J L Carey, H Kawakubo, et al.
The Journal of Biological Chemistry
|
August 26, 1994
Modulation by sphingolipids of calcium signals evoked by epidermal growth factor
P L Hudson, W A Pedersen, W S Saltsman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1995
Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo
M S Kurian, R S de la Cuesta, G L Waneck, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 2001
Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents
A M Trbovich, P M Sluss, V M Laurich, et al.
The Journal of Biological Chemistry
|
May 18, 2001
Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo
D L Segev, Y Hoshiya, A E Stephen, et al.
Endocrinology
|
July 1, 1992
Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain
D T MacLaughlin, P L Hudson, A L Graciano, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1990
An immunoassay to detect human müllerian inhibiting substance in males and females during normal development
P L Hudson, I Dougas, P K Donahoe, et al.
Journal of Andrology
|
September 8, 2001
Müllerian inhibiting substance inhibits testosterone synthesis in adult rats
V Sriraman, E Niu, J R Matias, et al.
Gynecologic Oncology
|
February 1, 1984
KLE: a cell line with defective estrogen receptor derived from undifferentiated endometrial cancer
G S Richardson, G R Dickersin, L Atkins, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1994
Developmental changes in mullerian inhibiting substance in the cynomolgus monkey, Macaca fascicularis
M M Lee, M L Gustafson, E Ukiyama, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2005
Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model
V Gupta, J L Carey, H Kawakubo, et al.
The Journal of Biological Chemistry
|
August 26, 1994
Modulation by sphingolipids of calcium signals evoked by epidermal growth factor
P L Hudson, W A Pedersen, W S Saltsman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1995
Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo
M S Kurian, R S de la Cuesta, G L Waneck, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 2001
Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents
A M Trbovich, P M Sluss, V M Laurich, et al.
The Journal of Biological Chemistry
|
May 18, 2001
Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo
D L Segev, Y Hoshiya, A E Stephen, et al.
Endocrinology
|
July 1, 1992
Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain
D T MacLaughlin, P L Hudson, A L Graciano, et al.
Page
of 8